Authors

• Mario Berger (ORCID: https://orcid.org/0000-0002-9048-3928)
• Hiddo J.L. Heerspink (ORCID: https://orcid.org/0000-0002-3126-3730)
• Faiez M. Zannad (ORCID: https://orcid.org/0000-0001-7456-1570)
• Bertram Pitt (ORCID: https://orcid.org/0000-0001-5880-275X)
• Richard Nkulikiyinka (ORCID: https://orcid.org/0009-0005-2145-7231)
• Laura Goea (ORCID: https://orcid.org/0000-0003-0473-2885)
• Peter Kolkhof (ORCID: https://orcid.org/0000-0003-3425-7528)
• Aidan MacNamara (ORCID: https://orcid.org/0000-0001-5958-2429)
• Richard J. Coward (ORCID: https://orcid.org/0000-0001-6183-2546)
• Sebastian Voß (ORCID: https://orcid.org/0009-0000-0891-1747)
• Andrea Scalise (ORCID: https://orcid.org/0000-0002-9367-5773)
• João Pedro Ferreira (ORCID: https://orcid.org/0000-0003-2422-4730)
• Peter R Rossing (ORCID: https://orcid.org/0000-0002-1531-4294)
• Adam Skubala (ORCID: https://orcid.org/0009-0000-0496-5713)
• Joachim Hanno

Institutions

• University of Copenhagen (DK)
• University Medical Center Groningen (NL)
• Steno Diabetes Centers (DK)
• Inserm (FR)
• Universidade do Porto (PT)
• University of Michigan (US)
• University of Bristol (GB)
• University of California San Diego (US)
• VA San Diego Healthcare System (US)
• French Clinical Research Infrastructure Network (FR)
• Bayer (Germany) (DE)
• Université de Lorraine (FR)

Publication Details

Journal

European Heart Journal

Published

2025-05-26

DOI

https://doi.org/10.1093/eurheartj/ehaf316

Citations

6

Primary Topic

Hormonal Regulation and Hypertension

Type

article

Field-Weighted Citation Impact

7.77

Funders

• Bayer